/Companies

Kerafast

Boston, US · Founded 2010 · Delaware corporation · 1 known investors

Find your way into Kerafast

Each arrow is one introduction. Sign up to fill in the first one.

180 people can intro you to Jennifer

Ask Phil Schwarz to introduce you to Jennifer Rossi

You →Phil · together at Ohio University →Jennifer

Sign up to find every way you can get introduced to Kerafast

  • Your email: who you already know at Kerafast, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kerafast team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.

Founders & leadership

JRJennifer Rossi
Jennifer RossiExecutiveJennifer Rossi holds a PhD in Molecular, Cell Biology, and Biochemistry from Brown University and has served as CEO of multiple companies through growth, scaling, and acquisition cycles.
RP
Robert P. BondarykExecutive

Board

ABAndrew Bouldin
Andrew BouldinBoard directorPartner at FCA Venture Partners
MAMatthew A King
Matthew A KingBoard directorManaging Partner at FCA Venture Partners
MLMatthew L. King
Matthew L. KingBoard directorManaging Partner at FCA Venture Partners
JEJohn E. Burch
John E. BurchBoard directorManaging Partner at FCA Venture Partners
KD
Kim D. WestmorelandBoard director
WE
William EmhiserBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 3 rounds · 2012–2016

▶$250KraisedMar 2016 · 1 investors · Other
Rule 506(c)
Officers, directors & promoters on the filing
  • Kim WestmorelandDirector
  • Robert P BondarykExecutive Officer, Director
  • Andrew BouldinDirector
  • William EmhiserDirector
  • Matthew KingDirector
Offering amount
$1.1M
Amount sold
$250K
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$634.8KraisedApr 2015 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BouldinDirector
  • Kim D WestmorelandDirector
  • William EmhiserDirector
  • Jennifer RossiExecutive Officer
  • Matthew A KingDirector
  • Robert P BondarykExecutive Officer, Director
Offering amount
$1M
Amount sold
$634.8K
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2012 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew L. KingDirector
  • William C. EmhiserExecutive Officer, Director
  • John E. BurchDirector
  • Kim D. WestmorelandDirector
  • Robert P. BondarykExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$500K
Proceeds to insiders
$12.5K
First sale
Mar 2012
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Kerafast.

Frequently asked questions

What does Kerafast do?
Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.
Who are Kerafast's investors?
Kerafast's investors include FCA Venture Partners.
How much funding has Kerafast raised?
Kerafast has disclosed $1.4M raised across 3 rounds.
Where is Kerafast headquartered?
Kerafast is headquartered in Boston, US.